Daiichi Sankyo Co Ltd (DSNKY)
35.48
+1.92
(+5.71%)
USD |
OTCM |
May 02, 16:18
Daiichi Sankyo Accounts Payable (Quarterly): 3.681B for March 31, 2024
Accounts Payable (Quarterly) Chart
Historical Accounts Payable (Quarterly) Data
Date | Value |
---|---|
March 31, 2024 | 3.681B |
December 31, 2023 | 3.235B |
September 30, 2023 | 3.134B |
June 30, 2023 | 2.979B |
March 31, 2023 | 3.182B |
December 31, 2022 | 2.733B |
September 30, 2022 | 2.300B |
June 30, 2022 | 2.418B |
March 31, 2022 | 2.661B |
December 31, 2021 | 2.389B |
September 30, 2021 | 2.372B |
June 30, 2021 | 2.414B |
March 31, 2021 | 2.697B |
December 31, 2020 | 2.341B |
September 30, 2020 | 2.199B |
June 30, 2020 | 2.077B |
March 31, 2020 | 2.506B |
December 31, 2019 | 2.057B |
September 30, 2019 | 2.277B |
June 30, 2019 | 2.628B |
March 31, 2019 | 2.820B |
December 31, 2018 | 2.358B |
September 30, 2018 | 2.258B |
June 30, 2018 | 2.007B |
March 31, 2018 | 2.128B |
Date | Value |
---|---|
December 31, 2017 | 1.803B |
September 30, 2017 | 1.730B |
June 30, 2017 | 1.738B |
March 31, 2017 | 1.966B |
December 31, 2016 | 1.813B |
September 30, 2016 | 2.253B |
June 30, 2016 | 2.249B |
March 31, 2016 | 2.152B |
December 31, 2015 | 1.926B |
September 30, 2015 | 1.815B |
June 30, 2015 | 1.786B |
March 31, 2015 | 1.962B |
December 31, 2014 | 2.232B |
September 30, 2014 | 2.098B |
June 30, 2014 | 2.115B |
March 31, 2014 | 2.385B |
December 31, 2013 | 657.24M |
September 30, 2013 | 663.30M |
June 30, 2013 | 666.11M |
March 31, 2013 | 2.399B |
December 31, 2012 | 781.71M |
September 30, 2012 | 970.03M |
June 30, 2012 | 710.46M |
March 31, 2012 | 2.715B |
December 31, 2011 | 762.44M |
Accounts Payable Definition
Accounting terminology for money that a company owes to vendors for services or products that it purchased on credit. Accounts payable appear on the balance sheet as a current liability.
Accounts Payable (Quarterly) Range, Past 5 Years
2.057B
Minimum
Dec 2019
3.681B
Maximum
Mar 2024
2.614B
Average
2.462B
Median
Accounts Payable (Quarterly) Benchmarks
AstraZeneca PLC | 19.70B |
Eisai Co Ltd | 525.28M |
Takeda Pharmaceutical Co Ltd | 3.430B |
Nxera Pharma Co Ltd | 30.09M |
PeptiDream Inc | 22.72M |